Miriam Olivola
Datos Biográficos
| ID | 7656754 |
|---|---|
| NOMBRE | Miriam Olivola |
| NOMBRES | Miriam |
| APELLIDO | Olivola |
| FIRMA | OLIVOLA M |
| AFILIACIONES | University of Pavia |
| ORCID | 0000-0003-0914-0539 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 4 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 4 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2022 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2026 |
| ÍNDICE H | 0 |
Personalizing esketamine treatment in TRD and TRBD
These findings highlight the importance of a personalized treatment approach in treatment- resistant depressive episode patients. Esketamine may be particularly beneficial in reducing cognitive rigidity, improving mentalization, and breaking the cognitive inflexibility that contributes to sustained negative depressive thinking patterns. Further research is needed to refine patient stratification and optimize treatment strategies for individuals w…
Efficacy and tolerability of vortioxetine monotherapy in SSRI-resistant OCD
This study provides preliminary evidence of the efficacy and tolerability of vortioxetine monotherapy in SSRI-resistant OCD. The observed improvements in OCD, depressive and anxiety symptoms suggest that vortioxetine may represent a valuable therapeutic option. Further prospective controlled trials are needed to confirm these findings
Risk factors for suicidal attempts in a sample of outpatients with treatment-resistant depression
The integrated treatment of comorbidities and substance abuse, which involves different mental health services, is fundamental in achieving the recovery of these patients. Our study supports the importance of performing a careful clinical evaluation of patients with TRD in order to identify factors associated with increased risk of suicide attempts
Age at onset of mental disorders worldwide
Promotion of good mental health, prevention, and early intervention before/at the onset of mental disorders improve outcomes. However, the range and peak ages at onset for mental disorders are not fully established. To provide robust, global epidemiological estimates of age at onset for mental disorders, we conducted a PRISMA/MOOSE-compliant systematic review with meta-analysis of birth cohort/cross-sectional/cohort studies, representative of the…
Sin obras prominentes en esta página.
Age at onset of mental disorders worldwide
Promotion of good mental health, prevention, and early intervention before/at the onset of mental disorders improve outcomes. However, the range and peak ages at onset for mental disorders are not fully established. To provide robust, global epidemiological estimates of age at onset for mental disorders, we conducted a PRISMA/MOOSE-compliant systematic review with meta-analysis of birth cohort/cross-sectional/cohort studies, representative of the…
Risk factors for suicidal attempts in a sample of outpatients with treatment-resistant depression
The integrated treatment of comorbidities and substance abuse, which involves different mental health services, is fundamental in achieving the recovery of these patients. Our study supports the importance of performing a careful clinical evaluation of patients with TRD in order to identify factors associated with increased risk of suicide attempts
Efficacy and tolerability of vortioxetine monotherapy in SSRI-resistant OCD
This study provides preliminary evidence of the efficacy and tolerability of vortioxetine monotherapy in SSRI-resistant OCD. The observed improvements in OCD, depressive and anxiety symptoms suggest that vortioxetine may represent a valuable therapeutic option. Further prospective controlled trials are needed to confirm these findings
Personalizing esketamine treatment in TRD and TRBD
These findings highlight the importance of a personalized treatment approach in treatment- resistant depressive episode patients. Esketamine may be particularly beneficial in reducing cognitive rigidity, improving mentalization, and breaking the cognitive inflexibility that contributes to sustained negative depressive thinking patterns. Further research is needed to refine patient stratification and optimize treatment strategies for individuals w…
Major depressive disorder (3 obras) · Antidepressant (2 obras) · Anxiety (2 obras) · Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 obras) · Depression (economics (2 obras) · Internal Medicine (2 obras) · Medicine (2 obras) · Psychiatry (2 obras) · Treatment of Major Depression (2 obras) · Adverse effect (1 obras)